Chad Turner

Chad Turner serves as a secondary procurement liaison within the CDC Office of Acquisition Services, supporting the strategic acquisition of critical public health infrastructure. His role involves coordinating contract execution for high-priority biomedical and diagnostic procurement initiatives that enable infectious disease surveillance, laboratory capacity building, and rapid response operations. He works closely with senior contracting officers to ensure alignment with CDC’s mission to advance scientific readiness, particularly in the areas of diagnostic testing, pharmaceutical manufacturing, and data-driven epidemiological tools. His procurement activities primarily support the acquisition of clinical diagnostics, laboratory reagents, and biopharmaceutical solutions essential for national health security. Turner maintains consistent collaboration with key industry partners including General Dynamics Information Technology, GlaxoSmithKline, Cepheid, MRIGLOBAL, and the New York City Health & Hospitals Corp. These relationships reflect a focus on established vendors with proven capabilities in FDA-regulated manufacturing, molecular diagnostics, and large-scale public health logistics. His working patterns emphasize reliability, regulatory compliance, and technical scalability, often engaging contractors with prior experience in federal biosafety and emergency response programs. Turner’s procurement portfolio reflects a strong preference for full and open competition, with 100% of acquisitions conducted without set-aside designations such as 8(a), HUBZone, or SDVOSB. This indicates a strategic prioritization of technical capability and operational readiness over socioeconomic targeting, consistent with the urgency and complexity of CDC’s public health missions. His primary procurement focus is on NAICS 325412 — Pharmaceutical Preparation Manufacturing — reflecting deep expertise in the acquisition of diagnostic kits, antiviral formulations, vaccine components, and clinical-grade reagents. He specializes in procuring high-complexity, temperature-sensitive, and rapidly deployable medical products critical to outbreak response and laboratory network modernization.